Healthpeak Properties (NYSE:DOC – Get Free Report) released its quarterly earnings data on Tuesday. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02, Zacks reports. The firm had revenue of $738.78 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.46 earnings per share. Healthpeak Properties updated its FY 2026 guidance to 1.710-1.750 EPS.
Healthpeak Properties Trading Up 12.7%
Shares of DOC stock opened at $18.61 on Wednesday. The firm has a 50-day moving average price of $16.93 and a 200 day moving average price of $17.14. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $19.68. The company has a market capitalization of $12.94 billion, a price-to-earnings ratio of 186.13, a PEG ratio of 2.25 and a beta of 1.00. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21.
Healthpeak Properties Announces Dividend
The business also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.6%. The ex-dividend date is Monday, June 15th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 1,220.00%.
Institutional Trading of Healthpeak Properties
Analysts Set New Price Targets
DOC has been the subject of a number of research analyst reports. Citigroup dropped their price target on Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating for the company in a research report on Wednesday, April 1st. Argus lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Wells Fargo & Company restated a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Wall Street Zen cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, UBS Group started coverage on shares of Healthpeak Properties in a report on Monday, April 20th. They issued a “neutral” rating and a $17.00 price target on the stock. Five analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $18.04.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Recommended Stories
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
